| 摘要 |
The invention concerns a solid pharmaceutical composition for oral administration, characterised in that it comprises a benzofurane derivative with antiarrythmic activity or one of its pharmaceutically acceptable salts, as active principle, and a pharmaceutically acceptable non-ionic hydrophilic surfactant, optionally associated with one or several pharmaceutical vehicles. |
